C

노을

376930KOSDAQ

49.5 / 100

Reference Date: 2026-10-23

Financial Score22.0 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 17.3% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Noul is a company specializing in the development and sale of on-device AI solutions, 'miLab™', for blood and cancer diagnostics. By automating microscopic pathology processes and integrating AI-based diagnostic technology, miLab™ enables high-precision diagnostics even in environments lacking specialized personnel or infrastructure. The solution currently offers three applications—malaria diagnosis, peripheral blood smear analysis, and cervical cell analysis—and targets the mid-sized diagnostic lab market, where it holds a competitive advantage due to its offline capabilities and cost-effectiveness.

Number of Employees

130people

Average Salary

73.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.51Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-87.04Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
21.04Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲89.2% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼14.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -72.7% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (37%)

Current 1,285Won52-week high 2,90052-week low 334
1-month return0.0Point

1m -17.26% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral기타시장안내 (관리종목 지정사유 추가우려)(시가총액 200억원 미달)2026-10-14